Olink Webinars

The right drug targets for the right patient – Using biomarkers to solve challenges in drug development

Dec 3, 2021 9:53:45 AM / by Olink posted in Multiomics, Drug discovery & development, Personalized medicine

0 Comments

Speakers:  Dr. Jürgen Braunger of Boehringer Ingelheim Pharma, Dr. Timothy Radstake of AbbVie & Dr. Christopher D. Whelan of Biogen

Read More

Maximizing the power of proteomic clinical trial profiling for better actionable insights - a new collaborative initiative from the SCALLOP consortium

Aug 12, 2021 10:31:53 AM / by Olink posted in Multiomics, Clinical research, Drug discovery & development, Proteogenomics

0 Comments

Speakers: Anders Mälarstig, Direct of Target science at Pfizer

Read More

Biomarker Discovery and Custom Panel Development for Multiple Sclerosis Disease Assessments Utilizing the Olink Platform

Aug 12, 2021 10:29:39 AM / by Olink posted in Neurology, Drug discovery & development, Multiple Sclerosis

0 Comments

Speakers:  Ferhan Qureshi, Vice President Biomarker Product Development at Octave Bioscience

Read More

Uncovering novel protein biomarkers in drug discovery and development: Targeting disease diagnosis and drug response monitoring

Aug 12, 2021 10:23:14 AM / by Olink posted in Neurology, Drug discovery & development

0 Comments

Speakers:  Christopher Whelan, Senior scientist in the Translational Biology Research Group at Biogen & Simina Ticau, Senior scientist at Alnylam Pharmaceuticals

Read More

Recent Posts

See all Olink publications